Organelle Dysfunction and Apoptosis in Liver Epithelia
Organelle Dysfunction and Apoptosis in Liver Epithelia
批准号:
6595118
负责人:
GREGORY J. GORES
金额:
$28.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-08-01 至 2008-05-31
关键词:
BCL2 gene /protein apoptosis cathepsin B cytochrome c cytotoxicity fibrosis gene targeting genetically modified animals hepatotoxin laboratory mouse liver cells liver disorder liver function lysosomes membrane activity membrane permeability mitochondria protein localization protein protein interaction sphingomyelin phosphodiesterase sphingosine tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall objective of this proposal is to define the cellular mechanisms culminating in lethal liver cell injury. Because of the importance of tumor necrosis factor-alpha (TNF-alpha) in human liver injury, our program is working on the cellular and subcellular mechanisms causing liver injury by this cytokine. Specifically, our long-term objectives are to understand the mechanisms involved in TNF-alpha-mediated hepatocyte apoptosis. Based on extensive preliminary data, we propose the novel CENTRAL HYPOTHESIS that TNF-alpha signals selective lysosomal permeabilization resulting in cathepsin B release into the cytosol, where it initiates mitochondrial dysfunction resulting in apoptosis and liver injury. We will now employ current and complementary, molecular, biochemical and cell biological approaches to ascertain how TNF-alpha triggers this unexplored pathway of apoptosis. Our proposal has three SPECIFIC AIMS. FIRST, we will directly test the hypothesis that TNF-alpha signal lysosomal permeabilization: a) by activating neutral sphingomyelinases through the adaptor protein FAN (factor associated with neutral sphingomyelinase) with subsequent sphingosine generation; and b) by a process dependent upon intra-lysosomal cathepsin B (i.e., cathepsin B-dependent cathepsin B release). SECOND, we will test the hypothesis that cytosolic cathepsin B mediates apoptosis: a) by activating the mitochondrial pathway of apoptosis; and b) by cleaving the proapoptotic member of the Bcl-2 family Bid, resulting in its activation and translocation to mitochondria where it induces cytochrome c release. FINALLY, we will test the hypothesis that cathepsin B mediates liver injury such that: a) cathepsin B knockout mice are resistant to liver injury following endogenous stimulation of TNF-alpha in the bile duct-ligated mouse; and b) cathepsin B knockout mice have reduced parameters of liver fibrosis following bile duct ligation. The proposal is innovative, technically and conceptually, as it tests new concepts for TNF-alpha mediated liver injury and apoptosis in general using sophisticated technologies. The significance of the information generated is that it will provide a framework for the potential development of novel therapeutic strategies effective in attenuating human liver injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cholestatic Liver Injury
-
批准号:10372002
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:GREGORY J. GORES
-
依托单位:
Cholestatic Liver Injury
-
批准号:10588191
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2020
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10468830
-
项目类别:
-
资助金额:$29.79万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10006083
-
项目类别:
-
资助金额:$33.81万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Project 2: Therapeutic Inhibition of Fibroblast Growth Factor and YAP Signaling in Cholangiocarcinoma: Preclinical Studies and Clinical Trial
-
批准号:10251133
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2018
-
负责人:GREGORY J. GORES
-
依托单位:
Comparative Medicine Core Facility Infrastructure Improvement
-
批准号:7934406
-
项目类别:
-
资助金额:$191.18万
-
财政年份:2010
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10630253
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10200781
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
Enrichment Program
-
批准号:10438739
-
项目类别:
-
资助金额:$4.32万
-
财政年份:2009
-
负责人:GREGORY J. GORES
-
依托单位:
LONG-ACTING OCTREOTIDE IN THE TREATMENT OF PATIENTS
-
批准号:7206098
-
项目类别:
-
资助金额:$0.21万
-
财政年份:2005
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8250599
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:6942769
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7069491
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7840512
-
项目类别:
-
资助金额:$28.61万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7569503
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8075463
-
项目类别:
-
资助金额:$28.32万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8846590
-
项目类别:
-
资助金额:$34.58万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Long-acting octreotide in treatment of advnced HCC
-
批准号:7042302
-
项目类别:
-
资助金额:$0.44万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:7233296
-
项目类别:
-
资助金额:$23.5万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
Organelle Dysfunction and Apoptosis in Liver Epithelia
-
批准号:8481539
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2003
-
负责人:GREGORY J. GORES
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: